AYTU

NASDAQ:AYTU

Aytu BioPharma, Inc.

Add to Watchlist
  • Stock

1.33

−1.11%

−0.87

USD last updated 19/08 02:06:19

Last Close

2.20

18/08 20:00

Market Cap

16.90M

Beta: −0.41

Volume Today

70.27K

Avg: 68.94K

PE Ratio

−0.52

PFCF: 3.71

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patie...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -4000-3000-2000-10002018-02-082020-02-132021-09-272023-09-272024-11-13

    Revenue (Estimate*)

    20M40M60M80M2018-02-082020-02-132021-09-272023-09-272024-11-13

    *Estimate based on analyst consensus